GlassScriptPhysician profile
Jose Desousa
NPI 1740276377
$2,126.38
in general payments reported to CMS, 2019-2025
23 companies · $14.40 in 2025
The $14.40 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,630 · 2020: $179 · 2023: $88.20 · 2024: $215 · 2025: $14.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $291.88 | 2019 | |
| Ucb, INC. | $233.49 | 2020-2024 | Rystiggo, Nayzilam |
| Emd Serono, INC. | $228.72 | 2019 | |
| Lundbeck LLC | $200.00 | 2019 | |
| Eisai INC. | $180.11 | 2019 | |
| Amgen INC. | $177.96 | 2019 | |
| Lilly USA, LLC | $139.61 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $136.70 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $92.44 | 2019-2020 | |
| Genentech USA, INC. | $86.34 | 2019 | |
| Akcea Therapeutics, INC. | $62.56 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $52.88 | 2019-2020 | |
| Celgene Corporation | $52.00 | 2023 | Zeposia |
| Amneal Pharmaceuticals LLC | $32.28 | 2019 | |
| Bausch Health US, LLC | $23.70 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.80 | 2024 | |
| Sumitomo Pharma America, INC. | $20.19 | 2023 | Aptiom |
| Catalyst Pharmaceuticals, INC. | $18.19 | 2019 | |
| Avanir Pharmaceuticals, INC. | $16.44 | 2019 | |
| Horizon Therapeutics Plc | $16.01 | 2023 | Uplizna |
| Novartis Pharmaceuticals Corporation | $15.32 | 2020 | |
| Pfizer INC. | $14.40 | 2025 | |
| Neurocrine Biosciences, INC. | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Desousa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.